Ranibizumab for Diabetic Macular Edema: Long-term Open-Label Extension of the Phase III Ride and Rise Trials

被引：0
|
作者：
Fung, Anne
Fu, Arthur
Zhang, Jiameng
Ehrlich, Jason S.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
591-P
引用
收藏
页码：A151 / A152
页数：2
相关论文
共 50 条
  • [31] Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema Report From RESTORE, RIDE, and RISE Trials
    Bressler, Neil M.
    Varma, Rohit
    Mitchell, Paul
    Suner, Ivan J.
    Dolan, Chantal
    Ward, James
    Ferreira, Alberto
    Ehrlich, Jason S.
    Turpcu, Adam
    [J]. JAMA OPHTHALMOLOGY, 2016, 134 (02) : 160 - 166
  • [32] Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE
    Pieramici, Dante J.
    Wang, Pin-wen
    Ding, Beiying
    Gune, Shamika
    [J]. OPHTHALMOLOGY, 2016, 123 (06) : 1345 - 1350
  • [33] Effect of less aggressive treatment on diabetic retinopathy severity scale scores: analyses of the RIDE and RISE open-label extension
    Goldberg, Roger A.
    Hill, Lauren
    Davis, Tatiana
    Stoilov, Ivaylo
    [J]. BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [34] Baseline predictors of functional outcomes in patients with diabetic macular edema (DME) in the RISE and RIDE trials
    Sophie, Raafay
    Lu, Na
    Campochiaro, Peter A.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [35] Long-Term Effects of Apixaban Confirmed in the Open-Label Extension of AVERROES Trial
    Chao, Tze-Fan
    Potpara, Tatjana S.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2021, 121 (04) : 405 - 407
  • [36] LONG-TERM SPARSENTAN TREATMENT IN FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)
    Trachtman, Howard
    Srivastava, Tarak
    Tesar, Vladimir
    Campbell, Kirk N.
    Rheault, Michelle N.
    Komers, Radko
    Murphy, Edward
    Prasad, Andy
    Gesualdo, Loreto
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S99 - S99
  • [37] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2390 - I2392
  • [38] Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial
    Shaibani, Aziz
    Biton, Victor
    Rauck, Richard
    Koch, Brigitte
    Simpson, Jeffrey
    [J]. EUROPEAN JOURNAL OF PAIN, 2009, 13 (05) : 458 - 463
  • [39] Long-Term Efficacy of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled POS: Results from a Phase III Open-Label Extension Trial
    Chung, Steve
    Faught, Raymond Edward
    Husain, Aatif
    Isojarvi, Jouko
    Doty, Pamela
    [J]. NEUROLOGY, 2011, 76 (09) : A376 - A376
  • [40] Open-label Phase III extension studies to evaluate the long-term safety and efficacy of ocrelizumab in relapsing MS and primary progressive MS
    Kuhelj, R.
    Deol-Bhullar, G.
    Garas, M.
    Chin, P.
    Hauser, S.
    Montalban, X.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 200 - 200
12345